Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis

Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis

US Patent 6156727 · Granted Dec 5, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

APOE mimetic peptides and higher potency to clear plasma cholesterol2025
ApoE mimetic peptides and higher potency to clear plasma cholesterol2020
Synthetic apolipoprotein E mimicking polypeptides and methods of use2016
Peptides and peptide mimetics to treat pathologies associated with eye disease2013
Synthetic apolipoprotein E mimicking polypeptides and methods of use2013
Synthetic apolipoprotein E mimicking polypeptides and methods of use2013
Orally administered peptides synergize statin activity2013
Synthetic single domain polypeptides mimicking apolipoprotein E and methods of u2011
Peptides and peptide mimetics to treat pathologies characterized by an inflammat2011
Peptides for treatment of scleroderma2011
Orally administered peptides synergize statin activity2010
Orally administered peptides synergize statin activity2010